Spiriva Respimat (Tiotropium Bromide)

Do’s

• The usual dosage of Spiriva Respimat is 2 sprays once daily.
• When using the inhaler for the first time or after not using it for more than 3 days or 21 days, follow the instructions for test sprays in the air. This helps ensure the inhaler is working properly.
• Inhale the medication by mouth as directed by your healthcare provider. Put your lips tightly around the mouthpiece and rinse your mouth after using the inhaler to prevent dry mouth and throat irritation
• If using other inhalers at the same time, wait at least 1 minute between the use of each medication.
• Use this medication regularly at the same time each day to get the most benefit from it.
• The mouthpiece of the inhaler should be cleaned at least once a week as directed.
• For patients using Spiriva Respimat to treat asthma, it may take 4 to 8 weeks before experiencing the full benefit of the drug
• Learn which inhalers to use every day and which to use if breathing suddenly worsens. Consult your healthcare provider if you experience new or worsening symptoms.

Don’ts

• Do not inhale more than 2 sprays in 24 hours.
• Avoid getting the medication into your eyes.
• Do not increase the dose or use the drug more often or for longer than prescribed.

Common Side Effects:

• Sore throat
• Dry mouth
• Upper respiratory infections, such as the common cold
• Sinusitis (swelling in the sinuses)
• Cough
• Headache
• Indigestion (upset stomach)
• Chest pain 

Not all individuals may experience the listed common side effects. Additionally, consult a healthcare provider for a comprehensive understanding of potential side effects of Spiriva Respimat and seek medical attention if any concerning symptoms arise.

Spiriva Respimat may interact with other drugs. Consult a healthcare provider to assess potential interactions with other medications.

When used to treat asthma, Spiriva Respimat should be used in addition to other medicines called inhaled corticosteroids. This is an important consideration for individuals using this medication for asthma management.

No dosage adjustment is required for geriatric, hepatically-impaired, or renally-impaired patients. However, patients with moderate to severe renal impairment given Spiriva Respimat should be monitored closely for anticholinergic effects.

Spiriva Respimat is not a rescue inhaler and should not be used to relieve sudden breathing problems caused by asthma or COPD.